← All organizations
First clinical trial
Feb 1, 2000Last known activity
Jun 30, 2017
Timeline
1990s
- Jun 1, 1998
Avid Bioservices— Founded
Drugs by trial phase (11 distinct, 22 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Astrocytoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Central Nervous System Neoplasms
- Glioblastoma
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- HIV Infections
- Lung Neoplasms
- Neoplasms
- Nervous System Neoplasms
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Recurrence
- Triple Negative Breast Neoplasms
Recent trials (25)
- NCT03139916CollaboratorPhase 2Jun 30, 2017
- NCT02685306Lead sponsorPhase 2Mar 1, 2016
- NCT02673814Lead sponsorPhase 2Feb 1, 2016
- NCT02651610Lead sponsorPhase 2/Phase 3Dec 1, 2015
- NCT01999673Lead sponsorPhase 3Dec 1, 2013
- NCT01632696Lead sponsorEarly Phase 1Jun 1, 2012
- NCT01335204CollaboratorPhase 1/Phase 2Jun 1, 2011
- NCT01323062CollaboratorPhase 1May 1, 2011
- NCT01273948Lead sponsorPhase 1/Phase 2Jan 1, 2011
- NCT01272791Lead sponsorPhase 2Jan 1, 2011
- NCT01272791Study chairPhase 2Jan 1, 2011
- NCT01273948Study chairPhase 1/Phase 2Jan 1, 2011
- NCT01160601Lead sponsorPhase 2Jun 1, 2010
- NCT01138163Lead sponsorPhase 2Jun 1, 2010
- NCT00669565Lead sponsorPhase 2Jul 1, 2008
Details
- Founded
- Clarence, NY, US Jun 1, 1998
- Last known activity
- Jun 30, 2017
Notes
formerly Peregrine Pharmaceuticals